We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+29.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$593M
AUM Growth
-$55.1M
(-8.5%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-21.07%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
448
New
146
Increased
26
Reduced
83
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
A10 Networks
ATEN
|
+$4.04M |
| 2 |
SAFE
Safehold
SAFE
|
+$4.02M |
| 3 |
Aspen Aerogels
ASPN
|
+$3.64M |
| 4 |
VRTV
VERITIV CORPORATION
VRTV
|
+$3.54M |
| 5 |
Cytokinetics
CYTK
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMKR
Emcore Corp
EMKR
|
+$5.08M |
| 2 |
Surgery Partners
SGRY
|
+$5.02M |
| 3 |
iHeartMedia
IHRT
|
+$4.9M |
| 4 |
American Outdoor Brands
AOUT
|
+$4.81M |
| 5 |
AVID
Avid Technology Inc
AVID
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.64% |
| 2 | Technology | 20.81% |
| 3 | Industrials | 13.93% |
| 4 | Consumer Discretionary | 13.4% |
| 5 | Financials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
226
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.3M | 0.22% |
22,933
| – | – |
|
227
BlueLinx
BXC
$707M
| $1.3M | 0.22% |
+26,507
| New | +$1.33M |
|
228
Beyond Air
XAIR
$3.98M
| $1.3M | 0.22% |
+291
| New | +$1.05M |
|
229
Astrana Health
ASTH
$1.77B
| $1.29M | 0.22% |
14,227
-10,701
| -43% | -$910K |
|
|
SCX
230
DELISTED
The L.S. Starrett Company
SCX
| $1.29M | 0.22% |
+102,998
| New | +$952K |
|
231
Globalstar
GSAT
$10.7B
| $1.27M | 0.21% |
+50,688
| New | +$1.24M |
|
232
Tenet Healthcare
THC
$21.1B
| $1.26M | 0.21% |
19,045
-16,059
| -46% | -$1.14M |
|
233
Academy Sports + Outdoors
ASO
$2.98B
| $1.25M | 0.21% |
31,252
-37,389
| -54% | -$1.49M |
|
|
RAPT
234
DELISTED
RAPT Therapeutics
RAPT
| $1.24M | 0.21% |
5,000
-5,378
| -52% | -$1.42M |
|
235
Invivyd
IVVD
$220M
| $1.24M | 0.21% |
+29,289
| New | +$1.09M |
|
236
Lantheus
LNTH
$6.59B
| $1.23M | 0.21% |
47,924
-8,370
| -15% | -$219K |
|
237
Cineverse
CNVS
$64.9M
| $1.22M | 0.21% |
+24,333
| New | +$857K |
|
|
VCRA
238
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.22M | 0.21% |
+26,660
| New | +$1.19M |
|
|
SEMR
239
DELISTED
Semrush
SEMR
| $1.21M | 0.2% |
+52,455
| New | +$1.21M |
|
240
TeraWulf
WULF
$8.52B
| $1.21M | 0.2% |
+42,835
| New | +$1.04M |
|
241
RF Industries
RFIL
$139M
| $1.2M | 0.2% |
+148,337
| New | +$1.24M |
|
242
Harvard Bioscience
HBIO
$29.1M
| $1.19M | 0.2% |
17,058
-3,641
| -18% | -$290K |
|
243
Inspired Entertainment
INSE
$175M
| $1.19M | 0.2% |
101,353
-24,100
| -19% | -$281K |
|
244
MVB Financial
MVBF
$388M
| $1.19M | 0.2% |
27,690
-18,237
| -40% | -$743K |
|
245
Capital Bancorp
CBNK
$615M
| $1.18M | 0.2% |
48,895
| – | – |
|
246
Jakks Pacific
JAKK
$293M
| $1.17M | 0.2% |
98,030
+347
| +0.4% | +$4.38K |
|
|
ZENV
247
DELISTED
Zenvia
ZENV
| $1.16M | 0.2% |
+84,545
| New | +$1.21M |
|
248
Clarus
CLAR
$143M
| $1.16M | 0.2% |
45,204
-31,655
| -41% | -$874K |
|
249
Karat Packaging
KRT
$940M
| $1.15M | 0.19% |
+54,758
| New | +$1.23M |
|
250
Red Violet
RDVT
$921M
| $1.15M | 0.19% |
+44,592
| New | +$1.18M |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q3 2021 Portfolio in Review
As of Q3 2021, EAM Investors held 448 positions worth $593M, down 8.5% from $648M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
EAM Investors withdrew a net $125M in Q3 2021, closing 174 positions and reducing 83 holdings. Its most notable exit was Emcore Corp, an estimated $5.08M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in A10 Networks worth $4.2M.
- EAM Investors's largest Q3 2021 buy was A10 Networks: 311,218 shares worth $4.2M.
- EAM Investors added most to Aspen Aerogels in Q3 2021, an estimated $3.64M increase.
- EAM Investors's biggest Q3 2021 reduction was Prothena Corp, cutting an estimated $2.48M.
- EAM Investors fully exited Emcore Corp in Q3 2021, selling an estimated $5.08M.
- EAM Investors's ten largest holdings make up 9.2% of its $593M portfolio in Q3 2021.
- EAM Investors opened 146 new positions and closed 174 in Q3 2021.
- EAM Investors's portfolio value fell 8.5% quarter-over-quarter to $593M.
Based on EAM Investors's 13F filing for Q3 2021, filed 12 Nov 2021.